PSAT1 Gene Phosphoserine aminotransferase deficiency Genetic Test
Introduction
The PSAT1 Gene Phosphoserine aminotransferase deficiency Genetic Test is a genetic test offered by DNA Labs UAE. This test analyzes the PSAT1 gene for mutations or variations that may cause phosphoserine aminotransferase deficiency, a rare genetic disorder affecting the metabolism of serine.
Test Components and Price
- Test Name: PSAT1 Gene Phosphoserine aminotransferase deficiency Genetic Test
- Components: NGS Technology
- Price: 4400.0 AED
Sample Condition
The test can be conducted using blood or extracted DNA. Alternatively, one drop of blood can be collected on an FTA card.
Report Delivery
The test results will be delivered within 3 to 4 weeks.
Test Type and Department
The PSAT1 Gene Phosphoserine aminotransferase deficiency Genetic Test falls under the category of Metabolic Disorders and is conducted in the Genetics department.
Pre Test Information
Prior to the test, it is recommended to provide the clinical history of the patient who is undergoing the PSAT1 Gene Phosphoserine aminotransferase deficiency NGS Genetic DNA Test. Additionally, a genetic counseling session is advised to draw a pedigree chart of family members affected by the condition.
Test Details
The PSAT1 Gene Phosphoserine aminotransferase deficiency NGS Genetic Test utilizes Next-Generation Sequencing (NGS) technology to analyze the PSAT1 gene for mutations or variations related to phosphoserine aminotransferase deficiency. This rare genetic disorder affects the metabolism of serine, an amino acid involved in various biochemical processes in the body.
The NGS technology allows for the detection of small genetic variations, such as single nucleotide polymorphisms (SNPs) or small insertions/deletions. By analyzing the DNA sample obtained from a blood sample or cheek swab, the test can identify any genetic changes responsible for phosphoserine aminotransferase deficiency.
The results of the test can aid healthcare providers in making an accurate diagnosis, determining appropriate treatment and management strategies, and providing genetic counseling to affected individuals and their families. It is important to note that this test should be ordered by a healthcare professional and interpreted by a qualified geneticist or genetic counselor.
Conclusion
The PSAT1 Gene Phosphoserine aminotransferase deficiency Genetic Test offered by DNA Labs UAE is a valuable tool in diagnosing and managing individuals with phosphoserine aminotransferase deficiency. With its use of NGS technology, this test provides detailed genetic information that can guide healthcare professionals in providing the best possible care to patients and their families.
| Test Name | PSAT1 Gene Phosphoserine aminotransferase deficiency Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for PSAT1 Gene Phosphoserine aminotransferase deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Phosphoserine aminotransferase deficiency |
| Test Details |
PSAT1 Gene Phosphoserine aminotransferase deficiency NGS Genetic Test is a genetic test that analyzes the PSAT1 gene for mutations or variations that may cause phosphoserine aminotransferase deficiency. Phosphoserine aminotransferase deficiency is a rare genetic disorder that affects the metabolism of serine, an amino acid involved in various biochemical processes in the body. NGS (Next-Generation Sequencing) technology is used to analyze the PSAT1 gene, which allows for the detection of small genetic variations, such as single nucleotide polymorphisms (SNPs) or small insertions/deletions. This test can help diagnose individuals with phosphoserine aminotransferase deficiency and provide information about the specific genetic changes that are responsible for the condition. The test involves obtaining a DNA sample, usually through a blood sample or cheek swab, and sequencing the PSAT1 gene using NGS technology. The resulting genetic data is then analyzed and compared to a reference sequence to identify any mutations or variations that may be associated with phosphoserine aminotransferase deficiency. The results of the test can help healthcare providers make an accurate diagnosis, provide appropriate treatment and management strategies, and offer genetic counseling to affected individuals and their families. It is important to note that this test is typically ordered by a healthcare professional and should be interpreted by a qualified geneticist or genetic counselor. |
